Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110950872A details a high-yield Boc-protection strategy for Avapritinib, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced 4-step synthesis of Trilaciclib intermediate via mild conditions. Reduces purification costs and enhances supply chain reliability for CDK4/6 inhibitors.
Novel patent CN119528902A offers high-yield KRAS G12D intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Novel route for Cabazitaxel (XRP6258) using DMSO/Acetic Anhydride. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Patent CN102666527B details high-yield synthesis for kinase inhibitors. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN101863861A reveals efficient beta-lactam route for Larotaxel, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel ionic liquid method for SU1498 production ensures high purity and cost efficiency, offering a scalable solution for reliable pharmaceutical intermediate suppliers targeting VEGFR2 inhibitors.
Patent CN107935997A reveals a cost-effective Osimertinib route avoiding expensive chloropyrimidine. Enhance supply chain reliability with scalable manufacturing.
Novel Rh-catalyzed method for 1,3-benzodiazepines with anticancer activity. Efficient route for pharmaceutical intermediates offering cost reduction.
Patent CN114181132A reveals a novel high-purity synthesis route for nintedanib intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN110669089B details a novel synthesis of 6-ketoestradiol from fermentation-derived precursors, offering high purity and reduced environmental impact for API manufacturing.
Patent CN110777391B reveals a green electroreduction method for gefitinib intermediates, offering high purity, reduced costs, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN112574112B details a green oxidative synthesis for N-substituted 2H-indazoles. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN111138492B details a high-yield Brigatinib synthesis avoiding column chromatography. This report analyzes cost reduction and supply chain reliability for API manufacturing.
Patent CN102010455B reveals a novel Decitabine synthesis avoiding isomer separation. High purity >99.85% via Barton-McCombie deoxygenation for cost-effective manufacturing.
Discover the optimized synthesis of quinoline angiogenesis inhibitors via CN102356063A. Enhance purity and safety in pharmaceutical intermediate manufacturing.
Patent CN112250639B details a novel Ru/Cu-catalyzed route for heterocyclic arylamines. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN107879989B details a robust synthetic route for bioactive benzodiazepines with antitumor activity, offering scalable solutions for pharmaceutical intermediate manufacturing.
Novel nickel-catalyzed oxidation route for Acalabrutinib key intermediate reduces cost and pollution while ensuring high purity for pharma supply chains.
Patent CN108299401B discloses a high-yield synthesis of 3-benzyl coumarin-imidazole salts. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.